Stereotactic radiosurgery (SRS) is a non-invasive technique that is transforming the management of benign intracranial lesions through its precision and preservation of healthy tissues. It is effective for meningiomas, trigeminal neuralgia (TN), pituitary adenomas, vestibular schwannomas, and arteriovenous malformations. SRS ensures high tumor control rates, particularly for Grade I meningiomas and vestibular schwannomas. For refractory TN, it provides initial pain relief > 80 %. The advent of technologies such as PET-MRI, hypofractionation, and artificial intelligence is further improving treatment precision, but challenges remain, including the management of late side effects and standardization of practice.